XETRA · BAS.DE
BASF Se
€53.33+€0.49 (+0.93%)
BASF Se’s quoted price sits in the upper half of its reported 52-week range, 3.12% below the high.
Loading market information…
XETRA · EVK.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Evonik Industries AG’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Evonik Industries AG’s forward annual dividend is €1.00 per share, paid annual. The forward yield is 4.76% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Evonik Industries AG’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of €0.55. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Evonik Industries AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment is responsible for delivering essential ingredients such as polyurethane additives, modified silicones, isophorones, epoxy hardeners, oil modifiers, fumed silicas, matting agents, TAA compounds, and acetylenic diol-based surfactants, which find use in consumer products and various industrial applications. In the Nutrition & Care division, Evonik provides compounds like amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and their derivatives, synthetic products, pharmaceutical-grade polymers, and DL-methionine. These are crucial for consumer goods, animal nutrition, and healthcare industries. The Smart Materials segment manufactures advanced substances including hydrogen peroxide, peracetic acid, various activated nickel and precious metal catalysts (for powder, oil, and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, and different types of silicas (fumed and precipitated). These serve a broad spectrum of industries including automotive, paints, coatings, adhesives, and construction. Through its Performance Materials segment, the company produces polymer materials and intermediate chemicals, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbents, specifically for the rubber, plastics, and automotive sectors. Lastly, the Technology & Infrastructure segment provides crucial internal services, encompassing site management, utilities and waste disposal, technical expertise, process technology, engineering, and logistics. Evonik maintains a significant international presence, with operations spanning across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. Founded in 1873, the firm's main offices are located in Essen, Germany, and it functions as a subsidiary of RAG-Stiftung.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:39 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 12, 2025 | €0.57+46.49% vs estimate | €3.78B+1.12% vs estimate |
|---|
| Q4 2024 | Mar 5, 2025 | €0.15-30.5% vs estimate | €3.60B+6.11% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | €0.58+23.4% vs estimate | €3.83B-5.62% vs estimate |
|---|
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
KEEP COMPARING
€53.33+€0.49 (+0.93%)
BASF Se’s quoted price sits in the upper half of its reported 52-week range, 3.12% below the high.
CHF 3,916.00+CHF 2.00 (+0.05%)
Givaudan S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.47% below the high.
€106.40+€0.65 (+0.61%)
dsm-firmenich AG’s quoted price sits in the upper half of its reported 52-week range, 3.14% below the high.
€60.20-€0.10 (-0.17%)
Covestro AG’s quoted price sits in the upper half of its reported 52-week range, 2.43% below the high.
$102.22+$2.96 (+2.98%)
RPM International Inc.’s quoted price sits in the lower half of its reported 52-week range, 16.06% below the high.
€77.35+€0.85 (+1.11%)
Syensqo SA/NV’s quoted price sits in the upper half of its reported 52-week range, 7.25% below the high.
$67.93+$1.26 (+1.89%)
Eastman Chemical Company’s quoted price sits in the lower half of its reported 52-week range, 18.62% below the high.
£36.13+£0.02 (+0.06%)
Croda International Plc’s quoted price sits in the upper half of its reported 52-week range, 1.66% below the high.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
